What AI adoption means for your scientific talent pipeline

​Much of the discussion surrounding artificial intelligence in biotechnology is focused on a single question: will AI replace scientists?

While understandable, this may not be the most important question facing the industry today.

Across biotech, some of the earliest and most visible applications of AI are delivering value in areas such as protocol complexity checks, safety narratives and the drafting of clinical reports. These are often described as the more routine or administrative aspects of scientific work, and they represent clear opportunities to improve efficiency and productivity. As AI continues to evolve, and as technologies such as quantum computing advance, it is likely that increasingly complex scientific tasks will also become candidates for automation.

However, there is a broader workforce challenge that deserves equal attention.

Many of the tasks currently being enhanced by AI have historically played an important role in developing scientific talent. They provided junior scientists with the opportunity to build experience, deepen their understanding and develop the judgement that comes from practical application. Over time, these experiences became the foundation for progression into more senior scientific and leadership roles.

For many professionals, this work represented the first steps on a career ladder that ultimately led to positions as principal scientists, technical experts and organisational leaders.

As organisations continue to integrate AI into their operations, an important question emerges, if AI performs the tasks that have traditionally helped scientists build experience, where will future scientific leaders develop the capabilities needed to progress?

The real talent risk may not be redundancy at the top of organisations. Instead, it may be the gradual erosion of the development opportunities that have historically prepared individuals for more senior responsibilities.

This raises a number of important considerations for biotechnology leaders. Where will the principal scientists and leadership teams of 2030 and 2035 come from? What will career progression look like in increasingly AI-enabled organisations? How will junior scientists develop the skills and experience that previous generations acquired through doing? And what should an entry-level scientific role look like in this new environment?

These are not simply questions about technology adoption. They are questions about workforce design.

The organisations that succeed in the coming years will not necessarily be those that adopt AI the fastest. They will be those that recognise the need to redesign workforce architecture, talent attraction strategies and early-career development pathways to reflect a changing world of work.

As the lower rungs of the traditional career ladder become increasingly automated, organisations must ensure that new pathways exist for people to develop the skills, experience and judgement required to lead in the future.

The biotechnology industry has always adapted to scientific and technological change. AI is no exception. The challenge now is to ensure that while work evolves, the development of future talent evolves with it.

The question for leaders is no longer whether AI will replace scientists, it's how they will rebuild the ladder that develops them.